U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607275) titled 'Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension' on May 07.
Brief Summary: Yufeng Ningxin, a traditional Chinese medicine, has demonstrated potential antihypertensive effects in animal studies and small clinical trials, but has not yet been rigorously evaluated in large randomized clinical trials. Here, the investigators conducted a double-blind, randomized controlled trial to assess the efficacy and safety of Yufeng Ningxin tablets in patients with hypertension.
Study Start Date: May 15
Study Type: INTERVENTIONAL
Condition:
Hypertension
Essential (Primary) Hypertension
Intervention:
DRUG...